Duke Dermatology is a leader in advanced treatment of skin disease. The first Chief of Duke Dermatology was Dr. J. Lamar Callaway, a founding member of the Society of Investigative…

INTRODUCTION Antiphospholipid antibody syndrome (APS) can cause catastrophic thrombotic events, with cutaneous manifestations as the first sign of APS in up to 41% of patients.1 It is important to promptly…

INTRODUCTION Chemotherapy agents contribute to a number of side effects in the skin. This table highlights the major cutaneous adverse reactions in commonly used chemotherapy agents.DISCLOSURES The authors have disclosed…

INTRODUCTION It is well known that many disease processes manifest in areas of trauma. For example, psoriasis can occur in predisposed individuals from an inciting event such as an excoriation.…

INTRODUCTION Griscelli syndrome (GS) is a rare autosomal recessive disorder characterized by partial albinism, hepatosplenomegaly, pancytopenia, hepatitis, immunologic abnormalities, and lymphohistiocytosis.1 Here, we describe a case of Griscelli syndrome associated…

INTRODUCTION Radiation therapy is a commonly used and clinically important treatment for a variety of malignancies. The limiting factor in radiation treatment is often skin tolerance, as radiation injury to…

Spray-On Cell-Based Therapy and Leg Ulcers The results of a multicenter, phase-2 trial that shows the efficacy of a spray-on, cell-based treatment of venous leg ulcers was published August 2…

ACNE VULGARISA Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris Sponsored by XOMA (US), LLC, the purpose of…

Maritza I. Perez MDMaritza I. Perez MD is a graduate of the University of Puerto Rico School of Medicine where she also completed her residency in dermatology. In addition, she…

Mark Lebwohl MD graduated from Columbia College in 1974 and from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai. Dr. Lebwohl…

We recently had a 29-year-old leprosy patient with a giant 13-cm PPD skin reaction including induration plus erythema. He had a positive QuantiFERON-TB Gold assay, a negative chest X-ray, and…